TARPLIN, DOWNS & YOUNG, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2024 · House · Senate · $80,000.00 income · posted Aug 3, 2026

Lobbying activity 4

Budget/Appropriations

federal budget issues

Health Issues

IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Taxation/Internal Revenue Code

orphan drug tax credit

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.